CI

At a glance

ClinicalIndex Comparison Record
Early Ph 1Completed· 48 enrolled
Drug / intervention
dual-chamber syringeother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01747928
NCT01747928Early Ph 1Completed

A Representative Users Study Of The Operating Characteristics Of The Caverject Delivery System

Pfizer·interventional·Posted Dec 12, 2012·Updated May 2, 2014

In Brief

A Early Phase 1 clinical trial evaluating dual-chamber syringe for Healthy. Completed, enrolled 48 participants across 1 site.

Detailed Summary

Usability testing of the dual-chambered syringe in conjunction with the proposed patient instructions for use.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesUnited States
Collaborators--

Timeline

Early Ph 1CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedDec 12, 2012
Enrollment StartMar 1, 2013
Primary CompletionMar 1, 2013
TodayJul 2, 2026
Enrollment to primary: 0 daysPosted 13.6 years ago

Interventions

dual-chamber syringeother

dual-chamber syringe for mock injection